학술논문

Long-Term Effects of Alemtuzumab on CD4+ Lymphocytes in Multiple Sclerosis Patients: A 72-Month Follow-Up
Document Type
Article
Source
In: Frontiers in Immunology. (Frontiers in Immunology, 28 February 2022, 13)
Subject
Language
English
ISSN
16643224